NA
PFE icon

Networth Advisors’s Pfizer PFE Stock Holding History

Networth Advisors’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.23K Buy
51
+37
+264% +$968 ﹤0.01% 315
2026
Q1 		$393 Hold
14
– – ﹤0.01% 363
2025
Q4 		$349 Buy
+14
New +$353 ﹤0.01% 364

Other funds holding PFE

Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Networth Advisors's PFE Position: Q2 2026 in Review

Networth Advisors increased its Pfizer (PFE) stake by 264% in Q2 2026, buying an estimated $968 and bringing the position to 51 shares worth $1.23K. The position accounts for ﹤0.01% of the portfolio, ranked #315.

Networth Advisors first reported a position in PFE in Q4 2025 and has held it in 3 quarters since. 1,694 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Networth Advisors held 51 shares of Pfizer worth $1.23K as of Q2 2026.
  • Networth Advisors bought 37 Pfizer shares in Q2 2026, an estimated $968.
  • Pfizer made up ﹤0.01% of Networth Advisors's portfolio in Q2 2026, its #315 holding.
  • Networth Advisors first reported a position in Pfizer in Q4 2025 and has held it in 3 quarters since.
  • 1,694 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Networth Advisors's 13F filing for Q2 2026, filed 22 Jul 2026.